, Tracking Stock Market Picks
Enter Symbol:
Cortex Pharmaceuticals, Inc. (COR) [hlAlert]

up 59.39 %

Cortex Pharmaceuticals, Inc. (COR) rated Outperform with price target $35 by Robert W. Baird

Posted on: Tuesday,  Jan 15, 2013  8:25 AM ET by Robert W. Baird

Robert W. Baird rated Outperform Cortex Pharmaceuticals, Inc. (NYSE: COR) on 01/15/2013, when the stock price was $30.56.
Since then, Cortex Pharmaceuticals, Inc. has gained 59.39% as of 01/13/2016's recent price of $48.71.
If you would have followed this Robert W. Baird's recommendation on COR, you would have gained 59.39% of your investment in 1093 days.

Cortex Pharmaceuticals, Inc. (Cortex) focuses on developing small molecule compounds that positively modulate AMPA-type glutamate receptors, a complex of proteins involved in the communication between nerve cells in the mammalian brain. These compounds, termed AMPAKINE compounds, enhance the activity of the AMPA receptor. The Company designs and develops these molecules as pharmaceuticals intended for the treatment of neurological and psychiatric diseases, and disorders that are known, or thought, to involve depressed functioning of pathways in the brain that use glutamate as a neurotransmitter. The Company?s clinical compound, CX717 is in Phase II clinical development. Diseases, such as alzheimer?s disease, mild cognitive impairment (MCI), attention deficit hyperactivity disorder (ADHD), schizophrenia, depression, respiratory depression caused by opiate analgesics, and possibly sleep apnea may benefit from treatment with AMPAKINE drugs.

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/15/2013 8:25 AM Buy
30.56 35.00
as of 12/13/2013
1 Week down  -1.92 %
1 Month down  -6.74 %
3 Months down  -9.81 %
1 YTD down  -5.03 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy